Strategic Partnerships Leverage existing and recent collaborations with Medtronic, Stanford Medicine, and OrthoIndy to position Surgical Theater as a preferred AR/XR integration partner for neurosurgery, spine, and orthopedics. Target hospitals and vendors connected to these institutions for co-marketing, pilot programs, and extended clinical workflows.

Expansion Opportunities High growth potential in specialty areas with demonstrated adoption such as spine, cranial, and orthopedic procedures. Pursue expansion into more centers that perform complex surgeries and are investing in AR/XR to improve visualization, planning accuracy, and patient understanding.

Workflow Integration Emphasize the platform’s ability to integrate into existing surgical workflows and preoperative-to-intraoperative alignment. Offer turnkey deployment with training and change management to reduce adoption friction in hospitals transitioning to XR-enabled care.

Financial Levers Highlight ROI through improved surgical accuracy, reduced operative times, and enhanced patient education. Present case studies and pilot programs to justify procurement for health systems with mid-to-large budgets and ongoing capital expenditure cycles.

Enterprise HealthTech Position as a scalable enterprise solution with safety and regulatory alignment (FDA-cleared XR platform). Target large health systems, academic centers, and device manufacturers seeking AR/VR augmentation, after establishing credibility via prior Medtronic and Stanford collaborations.